Wearable-Supported Prehabilitation and Rehabilitation for Patients Undergoing Surgery for Pancreatic Cancer
NCT07772258 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2026-08-19
Summary
The goal of this clinical trial is to evaluate whether a wearable-enabled prehabilitation and rehabilitation pathway can improve recovery and post-operative outcomes in adults undergoing surgery for pancreatic cancer or related pancreatic/periampullary conditions.
The main questions it aims to answer are:
Does a wearable-enabled prehabilitation and rehabilitation programme reduce post-operative complications within 30 and 90 days after surgery? Is the use of wearable devices and remote monitoring feasible, acceptable, and useful for patients and healthcare professionals during the perioperative pathway?
Researchers will compare patients receiving the wearable-enabled pathway with a matched historical control group who received standard care to determine whether the intervention is associated with improved surgical and recovery outcomes.
Participants will:
Provide informed consent and complete baseline assessments and questionnaires. Take part in the Greater Manchester Prehab4Cancer programme before surgery, including personalised exercise, nutritional support, and wellbeing support.
Wear a Corsano CardioWatch device to continuously monitor physiological and activity data.
Use home monitoring equipment, including weight scales and blood pressure monitoring devices.
Complete questionnaires and participant logs during prehabilitation and recovery.
Receive regular support from the research team during participation. Undergo pancreatic surgery and receive standard NHS perioperative care. Continue wearable monitoring and rehabilitation after hospital discharge. Be followed for up to 12 months after surgery using routine clinical data to assess recovery, complications, hospital utilisation, and survival.
Optionally participate in a focus group to discuss their experiences of wearable-enabled care.
Conditions
- Pancreatic Cancer
- Pancreatic Neoplasms
- Periampullary Carcinoma
- Pancreatic Surgery
- Perioperative Care
Interventions
- DEVICE
-
Corsano CardioWatch
A wearable monitoring device used throughout the perioperative pathway to collect continuous physiological and activity data, including measures such as physical activity, heart rate, respiratory rate, oxygen saturation, skin temperature, and sleep-related metrics.
- BEHAVIORAL
-
Prehab4Cancer Programme
A personalised prehabilitation and rehabilitation programme comprising exercise, nutritional support, and wellbeing support delivered before and after pancreatic surgery.
Sponsors & Collaborators
- collaborator INDUSTRY
-
Manchester University NHS Foundation Trust
lead OTHER_GOV
Principal Investigators
-
Lukas Hughes-Noehrer, PhD · Manchester University NHS Foundation Trust
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-10-01
- Primary Completion
- 2028-03-31
- Completion
- 2028-09-30
More Related Trials
-
The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent Platforms
NCT07310056 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Exercise to Improve Outcomes in Pancreatic Cancer
NCT07710495 ·Status: RECRUITING ·Phase: NA
-
Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients
NCT03490604 ·Status: COMPLETED
-
Enhancing Fitness Before Pancreatic Surgery
NCT02940067 ·Status: COMPLETED ·Phase: NA
-
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer
NCT05692323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms
NCT05225038 ·Status: COMPLETED ·Phase: NA
-
Preoperative Exercise in Pancreatic Cancer
NCT02648880 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program
NCT03865875 ·Status: UNKNOWN ·Phase: NA
-
Patient-centered REhabilitation Program to Advance REcovery
NCT07189000 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer
NCT03187951 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Home-based Prehabilitation in Pancreatic Resection
NCT05496777 ·Status: COMPLETED ·Phase: NA
-
Wearable Exercise Trackers in Cancer Rehabilitation
NCT03042884 ·Status: COMPLETED ·Phase: NA
-
Prehabilitation in Pancreatic Surgery
NCT03688867 ·Status: COMPLETED ·Phase: NA
-
Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
NCT07608458 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prehabilitation in High-risk Oncologic Surgery
NCT07638410 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Exercise and Nutrition to Improve Pancreatic Cancer Outcomes
NCT03256201 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prehabilitation in Patients With Cancer and Type 2 Diabetes
NCT05547594 ·Status: RECRUITING ·Phase: NA
-
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
NCT06423963 ·Status: RECRUITING ·Phase: NA
-
Assessment, Monitoring and Optimisation of Prehabilitation Patients Using Wearable Fitness Trackers
NCT06071650 ·Status: RECRUITING ·Phase: NA
-
Patient Empowerment for Major Surgery Preparation @ Home
NCT05167682 ·Status: COMPLETED
-
Prehabilitation in Oncological Patients Undergoing Major Gastrointestinal Surgery (PROGRESS)
NCT06404489 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT07651358 ·Status: RECRUITING ·Phase: NA
-
Senior Adult Hepatobiliary Prehab Study
NCT05921552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multimodal Prehabilitation in Cancer Surgery
NCT06788834 ·Status: RECRUITING ·Phase: NA
-
Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer
NCT02184663 ·Status: UNKNOWN ·Phase: NA